Elham Jafari

Daily dose of 2000–4000 IU vitamin D for 4–6 months was reported to reduce headache frequency and improve disability score in migraine sufferers, especially in those with aura [ 52]. Combination of 1000 IU vitamin D and 20 mg simvastatin reduced number of headache days [ 53]. Similarly, another combination therapy of vitamin D in three doses of 400, 800, and 5000 IU with amitriptyline for 6 months decreased the frequency of migraine attacks among children and adolescents with migrai

At least one of the signs and symptoms of nystagmus, ataxia, vomiting, pallor, and ear fullness should be present during the attacks. Other causes of vertigo such as vestibular disorders, seizures, and posterior fossa tumors should be excluded to establish a diagnosis. Drugs used to treat migraine may reduce the attacks.

Vestibular migraine (VM) (or migrainous vertigo) and migraine with brainstem aura (BM) (previously known as basilar-type migraine) are two principal clinical syndromes that are associated with vertigo. The International Headache Society (IHS) has accepted both VM and BM as migraine variants. On the other hand, IHS requires an aura with two or more brainstem symptoms in addition to visual, sensory, or dysphasic symptoms to qualify as BM